Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder

Trial Profile

Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Jun 2010

At a glance

  • Drugs Carbamazepine; Lithium; Olanzapine; Valproic acid
  • Indications Bipolar I disorders
  • Focus Therapeutic Use
  • Acronyms BMAC
  • Sponsors Eli Lilly
  • Most Recent Events

    • 09 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Oct 2008 Checked against the ClinicalTrials.gov record.
    • 28 Sep 2008 Planned number of patients is now 143 according to the ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top